Double-Blind, Randomized Trial Comparing Efficacy and Safety of Continuing Olanzapine Versus Switching to Quetiapine in Overweight or Obese Patients With Schizophrenia or Schizoaffective Disorder
Therapeutics and Clinical Risk Management
doi 10.2147/tcrm.s3153
Full Text
Open PDFAbstract
Available in full text
Date
August 1, 2008
Authors
Publisher
Informa UK Limited